Ascelia Pharma AB (publ) (ACE.ST)

SEK 3.1

(-2.36%)

Total Debt Summary of Ascelia Pharma AB (publ)

  • Ascelia Pharma AB (publ)'s latest annual total debt in 2023 was 1.06 Million SEK , up 119.21% from previous year.
  • Ascelia Pharma AB (publ)'s latest quarterly total debt in 2024 Q2 was 34.06 Million SEK , up 81.19% from previous quarter.
  • Ascelia Pharma AB (publ) reported annual total debt of 484 Thousand SEK in 2022, down -70.76% from previous year.
  • Ascelia Pharma AB (publ) reported annual total debt of 1.65 Million SEK in 2021, down -6.92% from previous year.
  • Ascelia Pharma AB (publ) reported quarterly total debt of 34.06 Million SEK for 2024 Q2, up 81.19% from previous quarter.
  • Ascelia Pharma AB (publ) reported quarterly total debt of 1.57 Million SEK for 2023 Q2, down -13.11% from previous quarter.

Annual Total Debt Chart of Ascelia Pharma AB (publ) (2023 - 2016)

Historical Annual Total Debt of Ascelia Pharma AB (publ) (2023 - 2016)

Year Total Debt Total Debt Growth
2023 1.06 Million SEK 119.21%
2022 484 Thousand SEK -70.76%
2021 1.65 Million SEK -6.92%
2020 1.77 Million SEK 1752.08%
2019 96 Thousand SEK -34.25%
2018 146 Thousand SEK 0.0%
2017 - SEK 0.0%
2016 - SEK 0.0%

Peer Total Debt Comparison of Ascelia Pharma AB (publ)

Name Total Debt Total Debt Difference
Alligator Bioscience AB (publ) 16.09 Million SEK 93.409%
Ziccum AB (publ) 857 Thousand SEK -23.804%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 4.97 Million SEK 78.691%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 24.48 Million SEK 95.667%
Genovis AB (publ.) 79.32 Million SEK 98.662%
Intervacc AB (publ) 181 Thousand SEK -486.188%
QuiaPEG Pharmaceuticals Holding AB (publ) 20.61 Million SEK 94.852%
Active Biotech AB (publ) 3 Million SEK 64.633%
Magle Chemoswed Holding AB (publ) 60.3 Million SEK 98.241%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) 5 Million SEK 78.78%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 71.4 Million SEK 98.514%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 7.82 Million SEK 86.446%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -150.236%
Egetis Therapeutics AB (publ) 108.6 Million SEK 99.023%
Karolinska Development AB (publ) 3.07 Million SEK 65.44%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) 2.58 Million SEK 58.876%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK -6.1%
Calliditas Therapeutics AB (publ) 979.13 Million SEK 99.892%
Camurus AB (publ) 24.5 Million SEK 95.671%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 27.56 Million SEK 96.151%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 866.76 Million SEK 99.878%
Cyxone AB (publ) 858 Thousand SEK -23.66%
ExpreS2ion Biotech Holding AB (publ) 1.71 Million SEK 37.989%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 36.8 Million SEK 97.117%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 666 Thousand SEK -59.309%
SynAct Pharma AB 637 Thousand SEK -66.562%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -24.824%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK 39.75%
BioInvent International AB (publ) 23.24 Million SEK 95.435%
Alzinova AB (publ) 800 Thousand SEK -32.625%
Oncopeptides AB (publ) 106.48 Million SEK 99.004%
Pila Pharma AB (publ) 773.08 Thousand SEK -37.243%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 98.831%
Diamyd Medical AB (publ) 30.67 Million SEK 96.541%
Xbrane Biopharma AB (publ) 231.47 Million SEK 99.542%
Diagonal Bio AB (publ) - SEK -Infinity%